X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

HELPFUL RESOURCES

Get information to help with your relapsing ms treatment decision

Whether you’re considering LEMTRADA or starting LEMTRADA, your healthcare team and your MS One to One® nurse are great choices for information and advice. Here are some other useful resources for learning more about LEMTRADA.

Patient profiles brochure with real LEMTRADA patient stories

REAL STORIES FROM REAL PATIENTS

Everyone with relapsing MS has a story to tell—a story of struggle, of hope, and of determination. Meet some real relapsing MS patients and learn why they decided to take an active role in their treatment. See how their determination led them to ask their healthcare providers about LEMTRADA.

Get your patient profiles brochure— HOW DO I KNOW IF LEMTRADA IS FOR ME?

Sign up

Download these resources now

If you’re considering LEMTRADA

A guide to learn about LEMTRADA treatment for relapsing MS

THE LEMTRADA BROCHURE

Learn everything you should know as you consider LEMTRADA for your relapsing MS treatment.

Download


Doctor discussion guide for relapsing MS

HEALTHCARE PROVIDER DISCUSSION GUIDE

Use this conversation starter during an appointment with your healthcare provider to talk about your condition and your treatment goals.

Download


If you’re starting LEMTRADA

A step by step guide for before, during and after your LEMTRADA treatment

STEP BY STEP

A handy guide to getting started with your LEMTRADA treatment, and the steps you need to take before, during, and after treatment.

Download

Find a LEMTRADA-certified prescriber oR healthcare facility

Find a certified prescriber or facility

Search for prescribers or healthcare facilities that are certified by the LEMTRADA REMS to prescribe and administer LEMTRADA.

Find a prescriber or a facility

Justin
LEMTRADA
PATIENT

THE SUPPORT
RESOURCES

HELPED ME
PREPARE.

See how patients prepared for treatment with LEMTRADA.

Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: